Brief: Shenzhen Hepalink Pharmaceutical Says Expected Delay In Publication Of Audited Annual Results Announcement For Year
29/03/2022 14:01
March 29 (Reuters) - Shenzhen Hepalink Pharmaceutical:
* EXPECTED DELAY IN PUBLICATION OF AUDITED ANNUAL RESULTS
ANNOUNCEMENT FOR YEAR
* CO EXPECTS TO PUBLISH AUDITED ANNUAL RESULTS FOR YEAR, ON
OR
BEFORE 12 APRIL 2022
* EXPECTS TO PUBLISH UNAUDITED CONSOLIDATED ANNUAL RESULTS
ON 30
MARCH
Further company coverage: 002399.SZ
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shenzhen Hepalink Pharmaceutical
See all newsBrief: HEPALINK 9M Revenue RMB3,796.9 Million
Brief: Shenzhen Hepalink Pharmaceutical Group Says Enoxaparin Sodium Injection Obtains New Manufacturer Authorization From EMA
Brief: Shenzhen Hepalink Pharmaceutical Group Posts QTRLY Net Profit Attributable Of RMB156.6 Million
Brief: Shenzhen Hepalink Pharmaceutical Posts Profit Attributable RMB646.7 Million For Year
Brief: Shenzhen Hepalink Pharmaceutical Says Enoparin Approved In Argentina